This Compendium includes a wealth of reports on drugs, biologics and medical
devices. The reports included consist of the authority to regulate drug
compounding; the law and intellectual property rights of biologics; federal
drug discovery and pricing; the FDA’s Safety and Innovation ACT (P.L. 112-114);
effects on pharmaceutical innovation and effects of generic brands;
infringement and experimental use under the Hatch-Waxman Act. Furthermore, the
reauthorization of the Prescription Drug User Fee Act (PDUFA); and how the FDA
approves drugs and regulates their safety and effectiveness.
Date of Report: December 17, 2012
Number of Pages: 267 Order Number: C-12010 Price: $79.95
For email and phone orders, provide a Visa, MasterCard, American Express, or Discover card
number, expiration date, and name on the card. Indicate whether you want e-mail
or postal delivery. Phone orders are preferred and receive priority processing.